Kozlov A M, Novikov A M, Bassalyk L S, Sof'ina Z P
Eksp Onkol. 1984;6(5):62-6.
The lipid-bound sialic acid (LSA) levels increased in the metastasizing Lewis lung carcinoma (3LL) and significantly decreased in blood plasma of the tumour-bearing mice after cyclophosphamide treatment correlating with the drug therapeutic effect. 5-fluorouracil that was less active in the used therapeutic doses did not cause similar changes in the LSA levels. No correlation was found between the LSA levels in adenocarcinoma 755 and the drug antitumour activity. It was observed that the content of hematoside, GM1 and GD1b sharply increases and GD3 and GD1a levels significantly decrease under the cyclophosphamide treatment of the Lewis tumour.
脂质结合唾液酸(LSA)水平在转移性Lewis肺癌(3LL)中升高,而在环磷酰胺治疗后荷瘤小鼠血浆中显著降低,这与药物治疗效果相关。在所用治疗剂量下活性较低的5-氟尿嘧啶未引起LSA水平的类似变化。腺癌755中的LSA水平与药物抗肿瘤活性之间未发现相关性。观察到在Lewis肿瘤的环磷酰胺治疗下,血型糖苷、GM1和GD1b的含量急剧增加,而GD3和GD1a水平显著降低。